Skip to main content

Table 4 ASCVD risk score for estimated 10-year risk of heart disease or stroke

From: Eliminating exogenous insulin therapy in patients with type 2 diabetes by duodenal ablation and GLP-1RA decreases risk scores for cardiovascular events

ASCVD Score

Baseline

6 months post DMR

Number of patients (%)

Number of patients (%)

 ≥ 20.0% (High risk)

6 (37.5%)

4 (25%)

7.5–19.9% (Intermediate risk)

5 (31.25%)

7 (6.25%)

5.0–7.4% (Borderline risk)

3 (18.75%)

0

 < 5.0% (Low risk)

2 (12.5%)

5 (18.75%)

Median risk score

13.6 (5.7–26.0)%

11.5 (4.2–22.5) %

Median ASCVD-free years (DIAL)

82 (81–83)

83 (81–84)

  1. ASCVD risk score was assessed by the ASCVD algorithm using the following variables: gender, age, systolic blood pressure, total cholesterol and smoking status in our patient population at baseline and 6 months post DMR [16]. Data are expressed as number of patients (% of population). ASCVD Risk score Calculator can be found on ACC/AHA ASCVD Risk Calculator (cvriskcalculator.com) and DIAL score calculator on https://u-prevent.com/calculators/dialModel
  2. DMR Duodenal Mucosal Resurfacing, ASCVD atherosclerotic cardiovascular disease, DIAL diabetes lifetime-perspective prediction
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840